Method of Deploying Intraluminal Device to Cardiac Stomach Region with Endoscopic-Laparoscopic System
Summary
USPTO granted patent US12599493B2 to BFKW, LLC for a method of deploying an intraluminal device to the cardiac region of the stomach. The invention involves trans-oral endoscopic deployment of the device with retention against the cardiac region while being fastened laparoscopically from the abdominal cavity with concurrent endoscopic visualization. The patent includes 18 claims covering both the method and the intraluminal system.
What changed
USPTO granted patent US12599493B2 to BFKW, LLC covering a method of deploying an intraluminal device to the cardiac region of the stomach and the associated intraluminal system. The device has a wall with an open portion adapted to align with the gastroesophageal junction, with the surface conformable to the cardiac portion of the stomach. The method combines trans-oral endoscopic deployment with laparoscopic fastening from the abdominal cavity while concurrently visualizing with an endoscope.
Medical device manufacturers in the intraluminal/prosthetic space should monitor this patent for potential licensing needs or design considerations. Healthcare institutions performing procedures in the cardiac stomach region may need to assess training implications for the combined endoscopic-laparoscopic technique. The patent establishes IP protection for a specific device configuration and deployment methodology combining multiple visualization and fastening approaches.
What to do next
- Monitor for updates
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method of deploying an intraluminal device and intraluminal system
Grant US12599493B2 Kind: B2 Apr 14, 2026
Assignee
BFKW, LLC
Inventors
Randal S. Baker, Frederick J. Walburn
Abstract
A method of deploying an intraluminal device to the cardiac region of the stomach and an intraluminal system used to deploy an intraluminal device to the cardiac region of the stomach, wherein the intraluminal device has a wall defining a surface and an open portion of the surface that is adapted to be aligned with the gastroesophageal (GE) junction. The surface and the cardiac portion of the stomach are conformable with each other. The method includes deploying the intraluminal device trans-orally to the stomach with an endoscopic deployment device and retaining the device against the cardiac region of the stomach with the open portion generally aligned with the GE junction. The intraluminal device is fastened to the stomach from the abdominal cavity with at least one laparoscopic instrument while concurrently visualizing the device with an endoscope in the stomach while it is being fastened. The laparoscopic instrument is adapted to respond to the endoscope in order to adjust location between the laparoscopic instrument and intraluminal device while the laparoscopic instrument is fastening the intraluminal device.
CPC Classifications
A61B 2018/00494 A61F 5/0069
Filing Date
2023-03-02
Application No.
18116676
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.